Acceder

Publicaciones - Terapias moleculares y biomarcadores de tumores sólidos

Cargando...
Piñero-Madrona A, Goméz-Ruiz AJ, Ruiz-Merino G, Martínez-Barba E, Cerezuela-Fuentes P, Rodríguez-López JN, Cabezas-Herrera J. Prognostic value of the Breslow:diameter ratio in cutaneous melanoma. J Am Acad Dermatol. 2019 Mar;80(3):806-808. doi: 10.1016/j.jaad.2018.09.034. Epub 2018 Oct 2. PubMed PMID: 30287323.
AÑO: 2019; IF: 6.898
Piñero-Madrona A, Ruiz-Merino G, Cerezuela Fuentes P, Martínez-Barba E, Rodríguez-López JN, Cabezas-Herrera J. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma. Clin Transl Oncol. 2019 Oct;21(10):1348-1356. doi: 10.1007/s12094-019-02064-4. Epub 2019 Feb 19. PubMed PMID: 30783917.
AÑO: 2019; IF: 2.392
Sánchez J, García A, Ruiz JM, Montes AM, Cabezas-Herrera J, Ros-Lara S, De la Cruz E, Gutiérrez AM. Porcine Breed, Sex, and Production Stage Influence the Levels of Health Status Biomarkers in Saliva Samples. Front Vet Sci. 2019 Feb 14;6:32. doi: 10.3389/fvets.2019.00032. eCollection 2019. PubMed PMID: 30838222; PubMed Central PMCID: PMC6382678.
AÑO: 2019
Castillo-Guardiola V, Sarabia-Meseguer MD, Marín-Vera M, Sánchez-Bermúdez AI, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer. Cancer Genet. 2018 Dec;228-229:1-4. doi: 10.1016/j.cancergen.2018.06.002. Epub 2018 Jun 23. PubMed PMID: 30553462.
AÑO: 2018; IF: 2.351
Marín Hernández C, Piñero Madrona A, Gil Vázquez PJ, Galindo Fernández PJ, Ruiz Merino G, Alonso Romero JL, Parrilla Paricio P. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol. 2018 Apr;20(4):476-483. doi: 10.1007/s12094-017-1732-0. Epub 2017 Aug 7. PubMed PMID: 28785911.
AÑO: 2018; IF: 2.392
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Terapias moleculares y biomarcadores de tumores sólidos